Document ID: chunk:federal_register_of_legislation:F2025C00036:reg:77
Version: federal_register_of_legislation:F2025C00036
Segment Type: reg
Provision Reference: reg 77
Character Range: 468753–469704

77  Preliminary assessment of applications for variation of permissible ingredients determination
 (1) The amendments of regulation 16GI and of items 28, 30, 32 and 34 of the table in clause 5 of Schedule 9 made by Schedule 6 to the Therapeutic Goods Legislation Amendment (2020 Measures No. 1) Regulations 2020 apply in relation to an application made under subsection 26BD(1) of the Act on or after the commencement of those amendments.
 (2) Regulation 16GI and items 28, 30, 32 and 34 of the table in clause 5 of Schedule 9, as in force immediately before the commencement of Schedule 6 to the Therapeutic Goods Legislation Amendment (2020 Measures No. 1) Regulations 2020, continue to apply on and after that commencement in relation to an application made under subsection 26BE(1) of the Act before that commencement.

Division 15—Application provisions relating to the Minamata Convention on Mercury (Consequential Amendments) Regulations 2021